Peter A. Forsyth
Department of Neuro-Oncology,
Department of Tumor Biology
H. Lee Moffitt Cancer Center & Research Institute
Peter A. Forsyth has not added Biography.
If you are Peter A. Forsyth and would like to personalize this page please email our Author Liaison for assistance.
Novel treatments for melanoma brain metastases.
Cancer control : journal of the Moffitt Cancer Center Oct, 2013 | Pubmed ID: 24077406
Cellular factors promoting resistance to effective treatment of glioma with oncolytic myxoma virus.
Cancer research Dec, 2014 | Pubmed ID: 25336188
Neurotrophin signaling via TrkB and TrkC receptors promotes the growth of brain tumor-initiating cells.
The Journal of biological chemistry Feb, 2015 | Pubmed ID: 25538243
BRAF-MEK inhibition in melanoma brain metastases: a new hope.
The Lancet. Oncology 07, 2017 | Pubmed ID: 28677560
Intrathecal trastuzumab in the management of HER2+ breast leptomeningeal disease: a single institution experience.
Breast cancer research and treatment Jun, 2018 | Pubmed ID: 29392582
Clinical outcomes of breast leptomeningeal disease treated with intrathecal trastuzumab, intrathecal chemotherapy, or whole brain radiation therapy.
Breast cancer research and treatment Jun, 2019 | Pubmed ID: 30859348
Breast leptomeningeal disease: a review of current practices and updates on management.
Breast cancer research and treatment Sep, 2019 | Pubmed ID: 31209686
Proteomic Analysis of CSF from Patients with Leptomeningeal Melanoma Metastases Identifies Signatures Associated with Disease Progression and Therapeutic Resistance.
Clinical cancer research : an official journal of the American Association for Cancer Research 05, 2020 | Pubmed ID: 31924735
A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease
Vincent Law1,2,
Margi Baldwin3,
Ganesan Ramamoorthi4,
Krithika Kodumudi4,
Nam Tran1,
Inna Smalley5,
Derek Duckett6,
Pawel Kalinski7,
Brian Czerniecki4,
Keiran S. M. Smalley2,
Peter A. Forsyth1,2
1Department of Neuro-Oncology, H. Lee Moffitt Cancer Center & Research Institute,
2Department of Tumor Biology, H. Lee Moffitt Cancer Center & Research Institute,
3Department of Comparative Medicine, University of South Florida,
4Department of Breast Oncology, H. Lee Moffitt Cancer Center & Research Institute,
5Department of Cancer Physiology, H. Lee Moffitt Cancer Center & Research Institute,
6Department of Drug Discovery, H. Lee Moffitt Cancer Center & Research Institute,
7Department of Medical Oncology, Roswell Park Comprehensive Cancer Center
Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease
Vincent Law1,2,
Inna Smalley3,
Brittany R. Evernden2,
Margaret Baldwin4,
Keiran S. M. Smalley1,
Peter A. Forsyth1,2
1Department of Tumor Biology, University of South Florida, H. Lee Moffitt Cancer Center & Research Institute,
2Department of Neuro-Oncology, University of South Florida, H. Lee Moffitt Cancer Center & Research Institute,
3Department of Cancer Physiology, University of South Florida, H. Lee Moffitt Cancer Center & Research Institute,
4Department of Comparative Medicine, University of South Florida, H. Lee Moffitt Cancer Center & Research Institute
关于 JoVE
版权所属 © 2024 MyJoVE 公司版权所有，本公司不涉及任何医疗业务和医疗服务。